2023-509339-17-00已完成1 期
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Pfizer Inc.
- 入组人数
- 6
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Medical Lead
Scientific
Pfizer Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults2024-517797-14-00Pfizer Inc.20
招募中
不适用
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaAsthmajRCT2031250163Pfizer Japan Inc.252
招募中
不适用
A Study to Learn About the Study Medicine Called PF-07868489 in People With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionjRCT2051240229Pfizer Japan Inc.90
进行中（未招募）
不适用
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of TreatmentjRCT2051230196Pfizer Japan Inc.510
招募中
不适用
A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease (EPIC-Peds)jRCT2031250096Pfizer Japan Inc.160